VAZZANA, NATALE
 Distribuzione geografica
Continente #
EU - Europa 914
NA - Nord America 852
AS - Asia 366
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 2.135
Nazione #
US - Stati Uniti d'America 851
CN - Cina 204
FR - Francia 161
IE - Irlanda 153
UA - Ucraina 152
SE - Svezia 134
TR - Turchia 112
GB - Regno Unito 111
IT - Italia 97
DE - Germania 53
IN - India 45
FI - Finlandia 32
BE - Belgio 9
AT - Austria 4
RU - Federazione Russa 4
VN - Vietnam 3
EU - Europa 2
GR - Grecia 2
CA - Canada 1
CL - Cile 1
IL - Israele 1
JP - Giappone 1
MT - Malta 1
PL - Polonia 1
Totale 2.135
Città #
Jacksonville 188
Chandler 187
Dublin 152
Southend 102
Dearborn 70
Princeton 63
Izmir 59
Nanjing 52
Beijing 46
Ashburn 36
Wilmington 34
Cambridge 32
Altamura 29
Nanchang 27
Ann Arbor 19
Chieti 18
Kunming 12
Hebei 10
Jiaxing 10
Brussels 9
Boardman 8
Washington 7
Changsha 6
Hangzhou 6
Pescara 6
Shenyang 6
Woodbridge 6
Tianjin 5
Grevenbroich 4
Jinan 4
New York 4
Norwalk 4
Anzola Dell'emilia 3
Dong Ket 3
Rome 3
Seattle 3
Boscotrecase 2
Changchun 2
Falls Church 2
Guangzhou 2
Hefei 2
Lanzhou 2
Misterbianco 2
Monmouth Junction 2
Munich 2
Paris 2
San Francisco 2
San Mateo 2
Tappahannock 2
Albano Laziale 1
Athens 1
Augusta 1
Bellante 1
Bergamo 1
Brentonico 1
Catania 1
Chengdu 1
Chongqing 1
Dallas 1
Düsseldorf 1
Greifswald 1
Helsinki 1
Jinhua 1
Leipzig 1
London 1
Melita 1
Mountain View 1
Nanping 1
Newcastle Upon Tyne 1
Newcastle upon Tyne 1
Ningbo 1
Novokuznetsk 1
Orange 1
Phoenix 1
Shanghai 1
Tokyo 1
Torino 1
Toronto 1
West Chester 1
Xian 1
Zgierz 1
Zhengzhou 1
Ürümqi 1
Totale 1.293
Nome #
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 108
Pentraxin 3 and platelet activation in obese patients after gastric banding 103
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 101
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 99
Platelet activation in obesity and metabolic syndrome. 86
The Recovery of Platelet Cyclooxygenase Activity Explains Interindividual Variability in Responsiveness to Low-Dose Aspirin in Patients With and Without Diabetes. 86
Soluble forms of RAGE in internal medicine. 78
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 77
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. 76
Oxidative stress drivers and modulators in obesity and cardiovascular disease: from biomarkers to therapeutic approach. 76
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 75
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 74
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 73
Diabetes mellitus and thrombosis 68
Thromboxane-Dependent Platelet Activation After Gastric Banding for Obesity. 68
Effects of high-amount-high-intensity exercise on in vivo platelet activation: Modulation by lipid peroxidation and AGE/RAGE axis 68
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 67
Endogenous Secretory RAGE in Obese Women: Association with Platelet Activation and Oxidative Stress 67
Determinants of increased cardiovascular disease in obesity and metabolic syndrome. 67
Soluble forms of RAGE in human diseases: clinical and therapeutical implications. 66
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 66
Obesity-driven inflammation and colorectal cancer 65
Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins. 64
Plasma levels of soluble CD36, platelet activation, inflammation, and oxidative stress are increased in type 2 diabetic patients 64
Antiplatelet Agents. Thromboxane receptors antagonists and/or synthase inhibitors 63
Diabetes mellitus 61
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the Low-HDL Phenotype 58
Plasma Levels Of Soluble CD36 In Type 2 Diabetes - A Link Between Platelet Activation, Inflammation And Oxidative Stress. 56
Soluble CD40L in Mediterranean Spotted Fever: Relation to oxidative stress and platelet activation. 55
Platelet Function in Health and Disease: from Molecular Mechanisms, Redox Considerations to Novel Therapeutic Opportunities. 51
Biomarkers of platelet activation in acute coronary syndromes 51
Variability in the response to antiplatelet treatment in diabetes mellitus. 50
Totale 2.287
Categoria #
all - tutte 6.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201970 0 0 0 0 0 0 0 0 3 3 0 64
2019/2020557 157 31 4 0 61 52 62 54 12 70 49 5
2020/2021184 33 2 36 0 4 43 11 6 11 28 4 6
2021/2022177 1 7 2 57 8 4 3 13 13 12 15 42
2022/2023519 38 83 31 46 50 106 31 32 75 10 6 11
2023/2024199 17 15 12 7 19 58 59 9 3 0 0 0
Totale 2.287